Cargando…
Cost‐of‐illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden—A population‐based register‐linkage study
The objective was to estimate the cost‐of‐illness of grades 1 and 2 metastatic gastroenteropancreatic neuroendocrine tumours (GEP‐NETs) in Sweden in 2013 in a population‐based study including all patients diagnosed between 2005 and 2013. Data were obtained from national registers, and patients who u...
Autores principales: | Lesén, Eva, Granfeldt, Daniel, Houchard, Aude, Berthon, Anthony, Dinet, Jérôme, Gabriel, Sylvie, Björstad, Åse, Björholt, Ingela, Elf, Anna‐Karin, Johanson, Viktor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285913/ https://www.ncbi.nlm.nih.gov/pubmed/30652364 http://dx.doi.org/10.1111/ecc.12983 |
Ejemplares similares
-
Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study
por: Lesén, Eva, et al.
Publicado: (2019) -
Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours – an analysis based on the CLARINET study
por: Meng, Yang, et al.
Publicado: (2017) -
Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study
por: Ambring, Anneli, et al.
Publicado: (2012) -
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center
por: Jalbert, Jessica J., et al.
Publicado: (2020) -
MON-301 Long-Acting SSA Treatment Patterns in Sweden From 2005 to 2017: A Nationwide Study
por: Olsson, Daniel S, et al.
Publicado: (2020)